The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer
Through a dual-modality molecular imaging approach, this research provides novel insight into anti-PD-1 therapy's effects on PD-L1 expression and glucose metabolism in normal organs of NSCLC patients, demonstrating that these parameters remain stable post-treatment.
Authors
- D.J. Hughes (ORCID: https://orcid.org/0000-0003-2641-7632)
- Gary Cook (ORCID: https://orcid.org/0000-0002-8732-8134)
- Damion Bailey
- Gitasha Chand
- Vicky Goh (ORCID: https://orcid.org/0000-0002-2321-8091)
- E. Lee
- Jessica Johnson (ORCID: https://orcid.org/0000-0002-4519-3120)
- Kathryn Adamson
- Matthew Severyn
Institutions
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- London Cancer (GB)
- King's College School (GB)
Publication Details
- Journal
- BJR|Open
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1093/bjro/tzaf010
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Research UK
- King's College London
- Engineering and Physical Sciences Research Council
- Centre For Medical Engineering, King’s College London